SARS-CoV-2 peptide KIADYNYKL (HLA-A*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
SARS-CoV-2 peptide KIADYNYKL (HLA-A*0201)

SARS-CoV-2 peptide KIADYNYKL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from SARS-CoV-2 is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: KIADYNYKL
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*0201

Podobne produkty

MHC I-Strep HLA-A*0201; Influenza M (GILGFVFTL)

MHC I-Strep HLA-A*0201; Influenza M (GILGFVFTL)

IBA Lifescience
Więcej
BST-2 peptide KLQDASAEV (HLA-A*0201)

BST-2 peptide KLQDASAEV (HLA-A*0201)

IBA Lifescience
Więcej
CMV IE-1 peptide QIKVRVDMV (HLA-B*0801)

CMV IE-1 peptide QIKVRVDMV (HLA-B*0801)

IBA Lifescience
Więcej